INCREASING ORAL BIOAVAILABILITY OF PROGESTERONE BY FORMULATION

被引：20
作者：
KINCL, FA
CIACCIO, LA
BENAGIANO, G
机构：
[1] CUNY,COLL STATEN ISL,STATEN ISL,NY 10301
[2] UNIV ROME,DEPT OBSTET & GYNECOL,I-00100 ROME,ITALY
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1978年 / 9卷 / 01期
关键词：
D O I：
10.1016/0022-4731(78)90106-1
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [41] Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment
    Mariana Colombo
    Gabriela de Lima Melchiades
    Luana Roberta Michels
    Fabrício Figueiró
    Valquiria Linck Bassani
    Helder Ferreira Teixeira
    Letícia Scherer Koester
    AAPS PharmSciTech, 20
  • [42] Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability
    Thakkar, Hetal P.
    Vasava, Deepika
    Patel, Arpita A.
    Dhande, Rahul D.
    THERAPEUTIC DELIVERY, 2020, 11 (02) : 83 - 96
  • [43] Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment
    Colombo, Mariana
    Melchiades, Gabriela de Lima
    Michels, Luana Roberta
    Figueiro, Fabricio
    Bassani, Valquiria Linck
    Teixeira, Helder Ferreira
    Koester, Leticia Scherer
    AAPS PHARMSCITECH, 2019, 20 (03)
  • [44] Enhanced dissolution, oral bioavailability and brain delivery by formulation schisantherin a into nanocrystals
    Chen, Tongkai
    Li, Ye
    Wu, Wenjin
    Yi, Xiang
    Lee, Simon Ming-Yuen
    Zheng, Ying
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 503 - 503
  • [45] Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
    Hofmann, Jiri
    Bartunek, Ales
    Hauser, Tomas
    Sedmak, Gregor
    Beranek, Josef
    Rysanek, Pavel
    Sima, Martin
    Slanar, Ondrej
    LEUKEMIA, 2023, 37 (12) : 2486 - 2492
  • [46] BIOAVAILABILITY OF DIGOXIN-HYDROQUINONE COMPLEX - NEW ORAL DIGOXIN FORMULATION
    BOCHNER, F
    HUFFMAN, DH
    SHEN, DD
    AZARNOFF, DL
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (05) : 644 - 647
  • [47] Unveiling the Potential of Nanosuspension Formulation Strategy for Improved Oral Bioavailability of Gefitinib
    Sayyad, Parvez
    Jha, Shikha
    Sharma, Reena
    Yadav, Vivek
    Jain, Sanyog
    AAPS PHARMSCITECH, 2025, 26 (02):
  • [48] Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study
    Vos, Cornelis F.
    Hemminga, Wietske L.
    Aarnoutse, Rob E.
    Ruhe, Henricus G.
    PHARMACOTHERAPY, 2024, 44 (06): : 480 - 484
  • [49] Effect of paclitaxel content in the DHP107 oral formulation on oral bioavailability and antitumor activity
    Jang, Yura
    Ko, Min Kyung
    Park, Ye Eun
    Hong, Jung Wan
    Lee, In-Hyun
    Chung, Hye Jin
    Chung, Hesson
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 48 : 183 - 192
  • [50] STUDIES ON THE EVALUATION OF BIOAVAILABILITY OF ORAL SOLID FORMULATION .5. EFFECTS OF DIETS ON THE BIOAVAILABILITY OF BISBENTIAMINE EXPERIMENTAL TABLETS AND THEIR RELATION TO PHYSIOLOGICAL AND FORMULATION FACTORS
    MIZOBE, M
    KOHNO, K
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1982, 102 (12): : 1162 - 1170
12345